<?xml version="1.0" encoding="UTF-8"?>
<p>Chloroquine (CQ) and hydroxychloroquine (HCQ), both derivatives of 4-aminoquinoline, are indicated to treat and prevent malaria. They are also used as DMARDs for rheumatoid arthritis, lupus erythematosus, and 
 <italic>porphyria cutanea tarda</italic>. In addition, the application for viral infections in off-label use has recently been investigated vigorously. The antiviral activity is through blocking the virus/cell fusion 
 <italic>via</italic> increasing endosomal pH and hindering the glycosylation of cellular receptors (
 <xref ref-type="fig" rid="fig2-1759720X20947296">Figure 2</xref>).
 <sup>
  <xref rid="bibr4-1759720X20947296" ref-type="bibr">4</xref>
 </sup>
</p>
